| Name | 3-[2-Fluoro-4-({[1-(2-phenoxyethyl)-1,2,3,4-tetrahydro-5-quinolinyl]methyl}amino)phenyl]propanoic acid |
|---|---|
| Synonyms |
Benzenepropanoic acid, 2-fluoro-4-[[[1,2,3,4-tetrahydro-1-(2-phenoxyethyl)-5-quinolinyl]methyl]amino]-
3-[2-Fluoro-4-({[1-(2-phenoxyethyl)-1,2,3,4-tetrahydro-5-quinolinyl]methyl}amino)phenyl]propanoic acid AS2034178 |
| Description | AS2034178 free base, a specific and orally active GPR40 agonist, exhibits glucose-dependent insulin secretion enhancement. AS2034178 free base has potential for type 2 diabetes mellitus research[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 657.9±55.0 °C at 760 mmHg |
| Molecular Formula | C27H29FN2O3 |
| Molecular Weight | 448.52900 |
| Flash Point | 351.7±31.5 °C |
| Exact Mass | 448.21600 |
| PSA | 61.80000 |
| LogP | 5.44 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.622 |